Everolimus - NDC Database (Page 3)
51991-992 Jan 28, 2025
Everolimus 5 mg Oral Tablet, for Suspension by Breckenridge Pharmaceutical, Inc.
Everolimus 5 mg Oral Tablet, for Suspension by Breckenridge Pharmaceutical, Inc.
60219-2279 Jan 14, 2025
Everolimus 2 mg Oral Tablet, for Suspension by Amneal Pharmaceuticals Ny LLC
Everolimus 2 mg Oral Tablet, for Suspension by Amneal Pharmaceuticals Ny LLC
60219-2280 Jan 14, 2025
Everolimus 3 mg Oral Tablet, for Suspension by Amneal Pharmaceuticals Ny LLC
Everolimus 3 mg Oral Tablet, for Suspension by Amneal Pharmaceuticals Ny LLC
60219-2281 Jan 14, 2025
Everolimus 5 mg Oral Tablet, for Suspension by Amneal Pharmaceuticals Ny LLC
Everolimus 5 mg Oral Tablet, for Suspension by Amneal Pharmaceuticals Ny LLC
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.